Morgan Stanley Emerging Markets Debt Closed Fund (MSD US) stock market data APIs
7.6682
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
Morgan Stanley Emerging Markets Debt Closed Fund Financial Data Overview
Price chart is built with
Anychart
Prev. Close
7.6682
Open
7.6682
High
7.7395
Low
7.69
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Morgan Stanley Emerging Markets Debt Closed Fund data using free add-ons & libraries
End-of-day & Earnings data
Get Morgan Stanley Emerging Markets Debt Closed Fund Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Morgan Stanley Emerging Markets Debt Closed Fund End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Morgan Stanley Emerging Markets Debt Closed Fund News
New
MSD calls off £1bn UK expansion amid government-big pharma tensions
Merck & Co (MSD) has ditched plans for its £1bn R&D centre in London, UK, while ceasing drug discovery and research efforts across the country in a double blow to the national life sciences sector. ...
Merck’s move to axe £1bn UK expansion was ‘commercial decision’, says minister
The Government has insisted US drugs giant Merck’s move to ditch plans for a £1 billion London centre was a “commercial decision” as it came under fire for under-investment in the sector. Merc...
US drugmaker scraps plans for £1bn UK research centre
One of America’s largest drug companies has ditched plans to open a £1bn research centre in London amid a growing row with the Government over surging NHS charges. Merck, which makes cancer drugs,...
Merck Demonstrates Ongoing Commitment to Advancing Cardiovascular Disease Management and Patient Care with New Data at the European Society of Cardiology Congress 2025
New real-world evidence and clinical trial data provide insights into treatment patterns for several serious cardiovascular diseases, including ASCVD, PH, and HFrEF RAHWAY, N.J., August 25, 2025--(BU...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
